Changes in thyroid cancer incidence, post‐2009 <scp>A</scp>merican Thyroid <scp>A</scp>ssociation guidelines

Shi, Lucy L.; DeSantis, Carol; Jemal, Ahmedin; Chen, Amy Y.

doi:10.1002/lary.26473

Cited by 36 publications

(35 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

Section: Detailed Epidemiology Of Thyroid Cancermentioning

confidence: 91%

“…A recently published study on adolescent cancer incidence during 1975-2012 has reported a 2.12% increase for females and 1.59% for males between 15 and 19 years of age [5]. However, there is a study indicating that thyroid cancer incidence trend has slowed following release of American Thyroid Association (ATA) guideline in 2009 [6,7]. It has been reported that overall thyroid cancer incidence had an increasing trend about 8% per year from 2000 to 2009.…”

Section: Detailed Epidemiology Of Thyroid Cancermentioning

confidence: 99%

“…It has been reported that overall thyroid cancer incidence had an increasing trend about 8% per year from 2000 to 2009. But APC showed a deceleration about 3% in men and 2.8% in women, which was conined to tumors less than 2.9 cm of size for women [7].Also, thyroid cancer-related mortality was estimated to consist 0.3% of all cancer-related deaths in 2016. A 5-year survival rate of 98.1% has been reported for thyroid cancer.…”

mentioning

confidence: 99%

See 2 more Smart Citations

Thyroid Cancers: Considerations, Classifications, and Managements

Khosravi¹,

Kouhi²,

Saeedi³

et al. 2017

Diagnosis and Management of Head and Neck Cancer

View full text Add to dashboard Cite

Rapidly increasing trend of thyroid cancer incidence has turned this disease into a global concern. An estimated number of 64,300 new cases of thyroid cancer occurred in men and women in 2016, which represents 3.8% of all new cancer cases of USA (htps://seer. cancer.gov/statfacts/html/thyro.html). Thus, there is a high possibility for every physician to encounter a case of thyroid cancer during his/her professional lifetime. In this chapter, we clariied epidemiology, diferent categories, and new approaches toward diagnosis and management of thyroid cancer.Keywords: thyroid cancer, epidemiology, diferentiated thyroid cancer, undiferentiated thyroid cancer, thyroid nodule Detailed epidemiology of thyroid cancerAs the most common endocrine cancer and ifth most common cancer in women, thyroid cancer includes approximately 1-1.5% of all new cases of cancer diagnosed annually in the USA based on previous data [1][2][3]. Thyroid cancer is more prevalent among women and those with positive family history of thyroid disease. Some prior studies have reported a worldwide increasing trend for thyroid cancer incidence in recent decades [4]. Annual percent change (APC) is a commonly used indicator for the assessment of changes in incidence. Based on US National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program, it has been reported 2.4% from 1980 to 1997 and 6.6% from 1997 to 2009 in both genders for thyroid cancer (data available at htp://seer.cancer.gov/statfacts/html/thyro.html).© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.According to [2009][2010][2011][2012][2013] data, the rate of new cases of thyroid cancer was 13.9 per 100,000 men and women per year (Figure 1). Table 1 summarizes number of new cases per 100,000 persons by race/ethnicity and sex. A recently published study on adolescent cancer incidence during 1975-2012 has reported a 2.12% increase for females and 1.59% for males between 15 and 19 years of age [5]. However, there is a study indicating that thyroid cancer incidence trend has slowed following release of American Thyroid Association (ATA) guideline in 2009 [6, 7]. It has been reported that overall thyroid cancer incidence had an increasing trend about 8% per year from 2000 to 2009. But APC showed a deceleration about 3% in men and 2.8% in women, which was conined to tumors less than 2.9 cm of size for women [7].Also, thyroid cancer-related mortality was estimated to consist 0.3% of all cancer-related deaths in 2016. A 5-year survival rate of 98.1% has been reported for thyroid cancer. Despite increasing trend of incidence, thyroid cancer mortality has a relatively stable rate about 0.5 cases per 100,000 persons both from 1973 to 2002 and 2009 to 2013 [8, 9].In conclusion, it seems that thyroid cancer has been following an ...

show abstract

Section: Detailed Epidemiology Of Thyroid Cancermentioning

confidence: 91%

Section: Detailed Epidemiology Of Thyroid Cancermentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

Thyroid Cancers: Considerations, Classifications, and Managements

Khosravi¹,

Kouhi²,

Saeedi³

et al. 2017

Diagnosis and Management of Head and Neck Cancer

View full text Add to dashboard Cite

show abstract

“…Over a 15‐year period (1995–2009), a 94% increase in the procedure was reported. The trend continues unabated, in keeping with the growing incidence of thyroid cancer over the last three decades …”

Section: Introductionmentioning

confidence: 99%

Histone Variants as Stem Cell Biomarkers for Long‐Term Injection Medialization Laryngoplasty

et al. 2018

View full text Add to dashboard Cite

show abstract

“…4 Additionally, the incidence rate for differentiated thyroid carcinomas in the United States is approximately 20 per 100,000 females and 6 per 100,000 males, predominantly papillary and follicular carcinoma. 5 Similarly, negative resection margins are the primary prevention of disease recurrence for thyroid cancer. 6 This study aims to investigate the ability of HSI using convolutional neural networks to classify tissue at the cancer margin.…”

Section: Introductionmentioning

confidence: 99%

Tumor margin classification of head and neck cancer using hyperspectral imaging and convolutional neural networks

Halicek

Little

Wang

et al. 2018

Medical Imaging 2018: Image-Guided Procedures, Robotic Interventions, and Modeling

Self Cite

View full text Add to dashboard Cite

One of the largest factors affecting disease recurrence after surgical cancer resection is negative surgical margins. Hyperspectral imaging (HSI) is an optical imaging technique with potential to serve as a computer aided diagnostic tool for identifying cancer in gross ex-vivo specimens. We developed a tissue classifier using three distinct convolutional neural network (CNN) architectures on HSI data to investigate the ability to classify the cancer margins from ex-vivo human surgical specimens, collected from 20 patients undergoing surgical cancer resection as a preliminary validation group. A new approach for generating the HSI ground truth using a registered histological cancer margin is applied in order to create a validation dataset. The CNN-based method classifies the tumor-normal margin of squamous cell carcinoma (SCCa) versus normal oral tissue with an area under the curve (AUC) of 0.86 for inter-patient validation, performing with 81% accuracy, 84% sensitivity, and 77% specificity. Thyroid carcinoma cancer-normal margins are classified with an AUC of 0.94 for inter-patient validation, performing with 90% accuracy, 91% sensitivity, and 88% specificity. Our preliminary results on a limited patient dataset demonstrate the predictive ability of HSI-based cancer margin detection, which warrants further investigation with more patient data and additional processing techniques to optimize the proposed deep learning method.

show abstract

Changes in thyroid cancer incidence, post‐2009 American Thyroid Association guidelines

Abstract: 2c. Laryngoscope, 127:2437-2441, 2017.

Cited by 36 publications

References 26 publications

Thyroid Cancers: Considerations, Classifications, and Managements

Thyroid Cancers: Considerations, Classifications, and Managements

Histone Variants as Stem Cell Biomarkers for Long‐Term Injection Medialization Laryngoplasty

Tumor margin classification of head and neck cancer using hyperspectral imaging and convolutional neural networks

Contact Info

Product

Resources

About